Arbutus Biopharma Stock Price (NASDAQ:ABUS)

Add to My Stocks
$3.2 $0.05 (1.59%) ABUS stock closing price Mar 24, 2017 (Closing)
Prev Close* : $3.15
Market Cap:
$173.32M
Day Low: $3.15
52 Week Low: $2.35
Open: $3.15
Volume: 59523
Day High: $3.25
52 Week High: $5.48
Dividend:
N/A

Latest Stock Market News

Latest Articles

Arbutus Biopharma News - From Partners

ABUS Stockcharts

View ABUS PE ratio, PS ratio stocks charts and compare with peers.
ABUS Chart
Note: Compare Arbutus Biopharma stock price history with the index and industry peers.

Arbutus Biopharma Valuation

PS ratio (
price to sales ratio
)
11.85
PB ratio (
price to book ratio
)
0.34

Arbutus Biopharma Financial Ratios

Asset Turnover
0.01
Receivables Turnover
13.73

ABUS Industry Peers

Company Price Change (%)
Albireo Pharma (ALBO)22.50.21 (0.92%)
Adocia (ADOCY)22.670 (0%)
Alnylam Pharma (ALNY)52.470.71 (1.34%)
Dicerna Pharma (DRNA)2.630.04 (1.5%)
Arrowhead Pharma (ARWR)1.870.02 (1.08%)
Marina Biotech (MRNA)0.240 (0%)
Benitec Biopharma (BNTC)2.690.42 (18.5%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Enzo Biochem (ENZ)8.430.52 (6.57%)
Peregrine Pharma (PPHM)0.7060.03 (4.44%)
Ophthotech (OPHT)3.530.15 (4.44%)
Kindred Biosciences (KIN)7.20.3 (4.35%)
Fortress Biotech (FBIO)3.60.14 (4.05%)
Immunomedics (IMMU)6.880.25 (3.77%)
Compugen (CGEN)4.350.15 (3.57%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017
CompanyPriceChange (%)
BioDelivery Sciences (BDSI)1.750.18 (9.35%)
Vital Therapies (VTL)3.850.15 (3.75%)
MannKind (MNKD)1.890.06 (3.08%)
PDL BioPharma (PDLI)1.980.05 (2.46%)
Sangamo BioSciences (SGMO)4.10.1 (2.38%)
Sorrento Therapeutics (SRNE)4.10.1 (2.38%)
Ultragenyx Pharma (RARE)70.321.67 (2.32%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017

Arbutus Biopharma Corp Stock News - Partner Headlines

Arbutus Biopharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues24.87M14.95M15.46M14.1M16.84M
Net Income-61.12M-38.83M-14.06M29.79M-10.05M
Total Operating Expense127.18M47.91M27.6M27.02M27.49M
view Arbutus Biopharma Corp income statement
balance sheet20152014201320122011
Total Assets712.29M118.17M71.71M52.32M14.15M
Total Liabilities164.61M30.14M12.52M11.61M8.78M
Shareholders Equity547.67M88.03M59.19M40.71M5.37M
view Arbutus Biopharma Corp balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-14.63M16.51M2.29M-2.43M1.14M
Net Cash From (Used By) Operating Activities-54.78M-12.42M-6.73M33.11M-7.77M
Increase (Decrease) In Prop Plant And Equipment-2.28M-0.97M-0.72M-0.01M-0.06M
view Arbutus Biopharma Corp cashflow statement

Arbutus Biopharma Stock Message Board

An investor needs to spend 3.2 to buy ABUS stock, as the closing Arbutus Biopharma stock price is 3.2. Looking at Arbutus Biopharma market capitalization, which currently stands at 173.32M, we can say that ABUS stock is a Micro cap stock. Arbutus Biopharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy ABUS stock than sell it, then Arbutus Biopharma stock price goes up. Conversely, if more investors wanted to sell ABUS stock than buy it, there would be greater supply than demand, and the stock price would fall. 59523 ABUS shares were traded yesterday, and Arbutus Biopharma stock chart shows that the ABUS stock quote hit a day high of 3.25 and day low of 3.15. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Arbutus Biopharma does not pay dividends. Arbutus Biopharma stock price history, gives the entire historical data for ABUS stock.